Price reductions for several medications

The official journal of Tuesday, October 20, 2026, announced new price decisions that will reduce costs for several medications, including the anticoagulant Xarelto, the pneumological treatment Ofev, and its generic equivalents, as well as the antiepileptic Diacomit. The hypocholesterolemic drug Liptruzet and the multiple sclerosis treatment Vumerity are also affected by the changes.

Xarelto prices drop by 12 percent

As of January 2, 2027, the public prices including all taxes (TTC) for oral forms of Xarelto will decrease by approximately 12 percent. For example, a box of 56 tablets at 2.5 mg will cost 20.36 euros, down from 23.25 euros, and the initiation kit will be priced at 35.45 euros, compared to 40.46 euros currently.

Liptruzet also sees a 12 percent reduction

On the same day, the price of Liptruzet will also decrease by approximately 12 percent, regardless of the dosage. A pack of 30 tablets will cost 17.16 euros, down from 19.60 euros, and a pack of 90 tablets will be priced at 51.03 euros, compared to 58.26 euros previously. This follows a recent price reduction for one of its components, ezetimibe.

Earlier price cuts for Ofev and its generics

Price reductions for three other medications will begin earlier, starting from December 1, 2026. Ofev will see its price decrease by approximately 11 percent, with the 120 or 180 soft capsules at 25 mg costing 1,171.79 euros, down from 1,313.61 euros. This change also affects various generic versions of Ofev based on nintedanib, including brands like Accord, Biogaran, and Teva.

Diacomit prices drop by 7.5 percent

Diacomit, used in the treatment of Dravet syndrome, will see a 7.5 percent price reduction. A pack of 60 capsules or sachets at 250 mg will cost 153.71 euros, down from 166.14 euros, and a pack of 60 units at 500 mg will be priced at 313.60 euros, compared to 338.60 euros previously.

Vumerity experiences the largest price cut

Vumerity, used in the treatment of multiple sclerosis, will record the most significant decrease of 19 percent. The price for 120 capsules will be 623.14 euros, down from 770.33 euros, offering the greatest reduction among the affected medications.